Aminoglycoside therapy. Current use and future prospects. - Wikidata - wikimedia - TriplyDB

Aminoglycoside therapy. Current use and future prospects.

Aminoglycoside therapy. Current use and future prospects.

http://www.wikidata.org/entity/Q37941557

about

Minocycline protection of neomycin induced hearing loss in gerbils.Potentiation of Aminoglycoside Activity in Pseudomonas aeruginosa by Targeting the AmgRS Envelope Stress-Responsive Two-Component System.

P2860

Q30412597-57D10CB7-731C-4170-A78A-F7606340E148 Q36933502-E4A8DF66-6E69-4F98-AD55-1AF50066C6B7

P2860

Aminoglycoside therapy. Current use and future prospects.

http://www.wikidata.org/entity/Q37941557

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Aminoglycoside therapy. Current use and future prospects.

@en

Aminoglycoside therapy. Current use and future prospects.

@nl

type

label

Aminoglycoside therapy. Current use and future prospects.

@en

Aminoglycoside therapy. Current use and future prospects.

@nl

prefLabel

Aminoglycoside therapy. Current use and future prospects.

@en

Aminoglycoside therapy. Current use and future prospects.

@nl

P1433

Q37941557-5D6F6287-DCAC-439A-AE65-1A8205B6AF68

P1476

Q37941557-5D15C11E-07C8-4F82-820B-0F5FD8CBA96F

P2093

Q37941557-6C55439A-632C-4BA6-B05D-5324CC61AC61

P2860

Q37941557-0F0ECA4F-27BA-416A-BB68-9BC3364A3975

Q37941557-270300F7-6405-4A1F-9C52-1928BEA40004

Q37941557-5764C67A-534E-43D3-A072-CD4C0A86E1A7

Q37941557-7230BD80-9AD3-4915-BB10-F69A27C60E68

Q37941557-901AD39E-F1E4-4528-B85C-39491C618532

Q37941557-A760BA28-5A65-4DCF-B689-62082E0A9372

Q37941557-A8777EF8-B8E0-41BA-BFD6-D2F2DD2E5EA1

Q37941557-AC5C0FBF-E3F5-4D2D-A50E-AA09A7365585

Q37941557-B88967F2-CCF3-4310-86A5-6E532C9DE3F9

Q37941557-BA8815DD-D484-4704-B942-B22205271520

P304

Q37941557-B8EF6AC5-3812-4BF2-B6BB-D2D3265F7749

P31

Q37941557-3B93A0B5-233B-4840-A25D-46042639AD39

P356

Q37941557-5402CDCA-19E4-4B7C-9CD9-1E7077CA40F6

P433

Q37941557-6AF23D91-1170-4988-AA64-6125220225E1

P478

Q37941557-4DB2DC9E-9B22-4B1A-884A-68F21D836DA9

P577

Q37941557-65B1F758-B9E2-496E-A4F2-2F8A27F37B0E

P5875

Q37941557-169A6ABF-B02A-44E4-A6BF-314C9E87F75D

P698

Q37941557-4475831E-4559-42E3-AD77-0808E1D03EE2

P356

P1433

Pharmaceutisch weekblad. Scientific edition

P1476

Aminoglycoside therapy. Current use and future prospects.

@en

P2093

Janknegt R

http://www.w3.org/2001/XMLSchema#string

P2860

In vivo activity of amikacin alone or in combination with clofazimine or rifabutin or both against acute experimental Mycobacterium avium complex infections in beige mice

Activity of amikacin against Mycobacterium avium complex under simulated in vivo conditions

Protective effect of piperacillin against nephrotoxicity of cephaloridine and gentamicin in animals

Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides

Aminoglycoside binding sites in the inner ears of guinea pigs.

Influence of hydrocortisone on gentamicin-induced nephrotoxicity in rats.

Antimicrobial susceptibility patterns of Nocardia asteroides.

Gentamicin pharmacokinetics in 1,640 patients: method for control of serum concentrations.

Aminoglycosides: current role in antimicrobial therapy.

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration.

P304

81-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF01967600

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

1990-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227258701

http://www.w3.org/2001/XMLSchema#string

P698

2196530

http://www.w3.org/2001/XMLSchema#string